409 related articles for article (PubMed ID: 6361300)
1. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
JAMA; 1984 Jan; 251(3):365-74. PubMed ID: 6361300
[TBL] [Abstract][Full Text] [Related]
2. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Rifkind BM
Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
[TBL] [Abstract][Full Text] [Related]
3. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
[TBL] [Abstract][Full Text] [Related]
4. The Lipid Research Clinics Coronary Primary Prevention Trial.
Rifkind BM
Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
Gordon DJ; Knoke J; Probstfield JL; Superko R; Tyroler HA
Circulation; 1986 Dec; 74(6):1217-25. PubMed ID: 3536151
[TBL] [Abstract][Full Text] [Related]
6. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW
Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415
[TBL] [Abstract][Full Text] [Related]
7. Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
Glueck CJ; Gordon DJ; Nelson JJ; Davis CE; Tyroler HA
Am J Clin Nutr; 1986 Oct; 44(4):489-500. PubMed ID: 3532756
[TBL] [Abstract][Full Text] [Related]
8. [Primary prevention of coronary disease by modification of the lipids].
Augustin J
Dtsch Med Wochenschr; 1984 Jun; 109(24):965-7. PubMed ID: 6376043
[No Abstract] [Full Text] [Related]
9. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
Cai HJ; Li ZX; Yang SM
Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
[TBL] [Abstract][Full Text] [Related]
11. Report on the Lipid Research Clinic trials.
Levy RI
Eur Heart J; 1987 Aug; 8 Suppl E():45-53. PubMed ID: 3315677
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol and cardiovascular disease. An overview of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC Coronary Primary Prevention Trial.
Tyroler HA
Am J Cardiol; 1984 Aug; 54(5):14C-19C. PubMed ID: 6382998
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J
Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
16. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
Schwandt P; Richter WO; Weisweiler P; Neureuther G
Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
[TBL] [Abstract][Full Text] [Related]
17. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
[TBL] [Abstract][Full Text] [Related]
18. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
Kronmal RA
JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
[No Abstract] [Full Text] [Related]
19. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV
Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091
[TBL] [Abstract][Full Text] [Related]
20. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
Angelin B; Einarsson K
Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
